FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Barbara Lisowska-Grospierre

Research Profile

Disorders

Genes & Molecular Sequences

Genes, MHC Class II

Chemicals & Drugs

Physiology

Anatomy

Procedures

Genetic Complementation Test

Co-author Network

Publications

TOP 3
Monia Ouederni; Sami Scerra; Fabien Touzot; Quentin B Vincent; Laurent Abel; Mohamed Bejaoui; Stéphane Blanche; Aziz Bousfiha; Julie Bruneau; Danielle Canioni; Jean-Laurent Casanova; Marianne Debré; Alain Fischer; Pierre Frange; Yves Levy; Barbara Lisowska-Grospierre; Capucine Picard
Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients.
Thomas Prod'homme; Benjamin Dekel; Giovanna Barbieri; Barbara Lisowska-Grospierre; Rina Katz; Dominique Charron; Catherine Alcaide-Loridan; Shimon Pollack
Splicing defect in RFXANK results in a moderate combined immunodeficiency and long-duration clinical course.
Felix Schnappauf; Sandra B Hake; Margarita M Camacho Carvajal; Séverine Bontron; Barbara Lisowska-Grospierre; Viktor Steimle
N-terminal destruction signals lead to rapid degradation of the major histocompatibility complex class II transactivator CIITA.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Barbara Lisowska-Grospierre (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Monia Ouederni; Sami Scerra; Fabien Touzot; Quentin B Vincent; Laurent Abel; Mohamed Bejaoui; Stéphane Blanche; Aziz Bousfiha; Julie Bruneau; Danielle Canioni; Jean-Laurent Casanova; Marianne Debré; Alain Fischer; Pierre Frange; Yves Levy; Barbara Lisowska-Grospierre; Capucine Picard
Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients.
Blood 2011;118(19):5108-18.
2003: Thomas Prod'homme; Benjamin Dekel; Giovanna Barbieri; Barbara Lisowska-Grospierre; Rina Katz; Dominique Charron; Catherine Alcaide-Loridan; Shimon Pollack
Splicing defect in RFXANK results in a moderate combined immunodeficiency and long-duration clinical course.
Immunogenetics 2003;55(8):530-9.
2003: Felix Schnappauf; Sandra B Hake; Margarita M Camacho Carvajal; Séverine Bontron; Barbara Lisowska-Grospierre; Viktor Steimle
N-terminal destruction signals lead to rapid degradation of the major histocompatibility complex class II transactivator CIITA.
European journal of immunology 2003;33(8):2337-47.
2003: Wojciech Wiszniewski; Marie-Claude Fondaneche; Pascale Louise-Plence; Ada Prochnicka-Chalufour; Françoise Selz; Capucine Picard; Françoise Le Deist; Jean-François Eliaou; Alain Fischer; Barbara Lisowska-Grospierre
Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II.
Immunogenetics 2003;54(11):747-55.
2002: Giovanna Barbieri; Virginie Deffrennes; Thomas Prod'homme; jocelyn vedrenne; Fabrice Baton; Claudio Cortes; Alain Fischer; María Rosa Bono; Barbara Lisowska-Grospierre; Dominique Charron; Catherine Alcaïde-Loridan
Isoforms of the class II transactivator protein.
International immunology 2002;14(8):839-48.
2002: Magda Dziembowska; Marie-Claude Fondaneche; jocelyn vedrenne; Giovanna Barbieri; Wojciech Wiszniewski; Capucine Picard; Andrew J Cant; Viktor Steimle; Dominique Charron; Catherine Alca-Loridan; Alain Fischer; Barbara Lisowska-Grospierre
Three novel mutations of the CIITA gene in MHC class II-deficient patients with a severe immunodeficiency.
Immunogenetics 2002;53(10-11):821-9.
2001: Jean Villard; krzysztof masternak; Barbara Lisowska-Grospierre; Alain Fischer; Walter Reith
MHC class II deficiency: a disease of gene regulation.
Medicine 2001;80(6):405-18.
2001: Wojciech Wiszniewski; Marie-Claude Fondaneche; Françoise Le Deist; M Kanariou; Françoise Selz; Nicole Brousse; Viktor Steimle; Giovanna Barbieri; Catherine Alcaide-Loridan; Dominique Charron; Alain Fischer; Barbara Lisowska-Grospierre
Mutation in the class II trans-activator leading to a mild immunodeficiency.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(3):1787-94.
2000: Wojciech Wiszniewski; Marie-Claude Fondaneche; N Lambert; krzysztof masternak; Capucine Picard; L Notarangelo; K Schwartz; Jerzy Bal; Walter Reith; C Alcaide; G de Saint Basile; Alain Fischer; Barbara Lisowska-Grospierre
Founder effect for a 26-bp deletion in the RFXANK gene in North African major histocompatibility complex class II-deficient patients belonging to complementation group B.
Immunogenetics 2000;51(4-5):261-7.
1998: Marie-Claude Fondaneche; Jean Villard; Wojciech Wiszniewski; Emmanuelle Jouanguy; A Etzioni; Françoise Le Deist; Ad Peijnenburg; Jean-Laurent Casanova; Walter Reith; Bernard Mach; Alain Fischer; Barbara Lisowska-Grospierre
Genetic and molecular definition of complementation group D in MHC class II deficiency.
Human molecular genetics 1998;7(5):879-85.
1998: Frédéric Altare; Emmanuelle Jouanguy; S Lamhamedi-Cherradi; M C Fondanéche; C Fizame; F Ribiérre; G Merlin; Z Dembic; R Schreiber; Barbara Lisowska-Grospierre; Alain Fischer; E Seboun; Jean-Laurent Casanova
A causative relationship between mutant IFNgR1 alleles and impaired cellular response to IFNgamma in a compound heterozygous child.
American journal of human genetics 1998;62(3):723-6.
1997: Jean Villard; Barbara Lisowska-Grospierre; P van den Elsen; Alain Fischer; Walter Reith; Bernard Mach
Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency.
The New England journal of medicine 1997;337(11):748-53.
1995: Anne Durandy; Geneviève de Saint Basile; Barbara Lisowska-Grospierre; J F Gauchat; M Forveille; R A Kroczek; J Y Bonnefoy; Alain Fischer
Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(4):1560-8.
1995: C Klein; Marina Cavazzana-Calvo; Françoise Le Deist; Nada Jabado; Malika Benkerrou; Stéphane Blanche; Barbara Lisowska-Grospierre; C Griscelli; Alain Fischer
Bone marrow transplantation in major histocompatibility complex class II deficiency: a single-center study of 19 patients.
Blood 1995;85(2):580-7.
1994: Viktor Steimle; Claire-Anne Siegrist; A Mottet; Barbara Lisowska-Grospierre; Bernard Mach
Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.
Science (New York, N.Y.) 1994;265(5168):106-9.
1994: Barbara Lisowska-Grospierre; M C Fondaneche; M P Rols; C Griscelli; A Fischer
Two complementation groups account for most cases of inherited MHC class II deficiency.
Human molecular genetics 1994;3(6):953-8.
1993: C Klein; Barbara Lisowska-Grospierre; F LeDeist; Alain Fischer; C Griscelli
Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome.
The Journal of pediatrics 1993;123(6):921-8.
1993: C Soudais; Jean-Pierre De Villartay; Françoise Le Deist; Alain Fischer; Barbara Lisowska-Grospierre
Independent mutations of the human CD3-epsilon gene resulting in a T cell receptor/CD3 complex immunodeficiency.
Nature genetics 1993;3(1):77-81.
1993: C Soudais; Jean-Pierre De Villartay; Françoise Le Deist; Alain Fischer; Barbara Lisowska-Grospierre
Genetic analysis of the human CD3-epsilon gene in a T cell receptor/CD3 immunodeficiency.
Immunodeficiency 1993;4(1-4):117-9.
1992: G Thoenes; C Soudais; Françoise Le Deist; C Griscelli; Alain Fischer; Barbara Lisowska-Grospierre
Structural analysis of low TCR-CD3 complex expression in T cells of an immunodeficient patient.
The Journal of biological chemistry 1992;267(1):487-93.
1991: Françoise Le Deist; Geneviève de Saint Basile; Fabienne Mazerolles; G Thoenes; Jean-Pierre De Villartay; Nadine Cerf-Bensussan; Barbara Lisowska-Grospierre; C Griscelli; Alain Fischer
Primary membrane T cell immunodeficiencies.
Clinical immunology and immunopathology 1991;61(2 Pt 2):S56-60.
1991: Françoise Le Deist; G Thoenes; J Corado; Barbara Lisowska-Grospierre; Alain Fischer
Immunodeficiency with low expression of the T cell receptor/CD3 complex. Effect on T lymphocyte activation.
European journal of immunology 1991;21(7):1641-7.
1990: G Thoenes; Françoise Le Deist; Alain Fischer; C Griscelli; Barbara Lisowska-Grospierre
Immunodeficiency associated with defective expression of the T-cell receptor-CD3 complex.
The New England journal of medicine 1990;322(19):1399.
1989: M T Dimanche-Boitrel; F Le Deist; A Quillet; Alain Fischer; C Griscelli; Barbara Lisowska-Grospierre
Effects of interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha) on the expression of LFA-1 in the moderate phenotype of leukocyte adhesion deficiency (LAD).
Journal of clinical immunology 1989;9(3):200-7.
1989: C Griscelli; Barbara Lisowska-Grospierre; B Mach
Combined immunodeficiency with defective expression in MHC class II genes.
Immunodeficiency reviews 1989;1(2):135-53.
1989: P Gönczy; Walter Reith; Emmanuèle Barras; Barbara Lisowska-Grospierre; C Griscelli; M R Hadam; Bernard Mach
Inherited immunodeficiency with a defect in a major histocompatibility complex class II promoter-binding protein differs in the chromatin structure of the HLA-DRA gene.
Molecular and cellular biology 1989;9(1):296-302.
1988: M T Dimanche-Boitrel; A Guyot; Geneviève de Saint Basile; Alain Fischer; C Griscelli; Barbara Lisowska-Grospierre
Heterogeneity in the molecular defect leading to the leukocyte adhesion deficiency.
European journal of immunology 1988;18(10):1575-9.
1988: Walter Reith; S Satola; C H Sanchez; I Amaldi; Barbara Lisowska-Grospierre; C Griscelli; M R Hadam; Bernard Mach
Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X.
Cell 1988;53(6):897-906.
1988: Nadine Cerf-Bensussan; Anne Jarry; T Gnéragbé; N Brousse; Barbara Lisowska-Grospierre; C Griscelli; D Guy-Grand
Monoclonal antibodies specific for intestinal lymphocytes.
Monographs in allergy 1988;24():167-72.
1987: Nadine Cerf-Bensussan; Anne Jarry; Nicole Brousse; Barbara Lisowska-Grospierre; D Guy-Grand; C Griscelli
A monoclonal antibody (HML-1) defining a novel membrane molecule present on human intestinal lymphocytes.
European journal of immunology 1987;17(9):1279-85.
1987: Nadine Cerf-Bensussan; Anne Jarry; N Brousse; Barbara Lisowska-Grospierre; C Griscelli; D Guy-Grand
Monoclonal antibodies specific for human and rat intestinal lymphocytes.
Advances in experimental medicine and biology 1987;216A():483-91.
1986: Nadine Cerf-Bensussan; D Guy-Grand; Barbara Lisowska-Grospierre; C Griscelli; A K Bhan
A monoclonal antibody specific for rat intestinal lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1986;136(1):76-82.
1984: W Karwowska; G de Saint Basile; Barbara Lisowska-Grospierre
Antibody levels to Candida albicans carbohydrate and major cytoplasmic antigens isolated from standard and patient strains.
Annales d'immunologie 1984;135D(2):145-59.
1984: W Karwowska; Barbara Lisowska-Grospierre
Diagnostic significance of the human antibody response to a major cytoplasmic antigen of C. albicans.
Immunology letters 1984;8(3):127-9.
1981: G de Saint-Basile; Barbara Lisowska-Grospierre; C Griscelli
Immune response to Toxoplasma gondii in man. I. Common idiotypic determinants of toxoplasma-specific human antibodies.
Annales d'immunologie 1981;132C(3):351-63.